Summary
This narrative review examines the potential therapeutic role of phytochemicals in mitigating coronavirus-associated lung injury, particularly during COVID-19 infection. The authors synthesise evidence for anti-inflammatory, antioxidant, and antiviral properties of candidate phytochemicals, highlighting inhibitory mechanisms targeting inflammatory and oxidative pathways implicated in SARS-CoV-2 pathogenesis. The review suggests phytochemicals may represent lead compounds for therapeutic development, though clinical evidence remains preliminary.
Regional applicability
The study is a mechanistic review without regional specificity or clinical data. Findings are potentially applicable across jurisdictions, but transfer to United Kingdom clinical practice would require subsequent controlled trials and regulatory evaluation.
Key measures
Phytochemical anti-inflammatory and antioxidant effects; anti-SARS-CoV-2 activity; inhibition of inflammatory and oxidative mediators
Outcomes reported
The study reviewed candidate phytochemicals and their mechanisms of action in treatment and protection of lung injuries induced by COVID-19 infection. It examined inhibitory effects on inflammatory and oxidative pathways involved in SARS-CoV-2-associated lung pathogenesis.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.